{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,27]],"date-time":"2025-11-27T16:49:50Z","timestamp":1764262190017,"version":"3.46.0"},"reference-count":34,"publisher":"MDPI AG","issue":"23","license":[{"start":{"date-parts":[[2025,11,27]],"date-time":"2025-11-27T00:00:00Z","timestamp":1764201600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Diagnostics"],"abstract":"<jats:p>Background\/Objectives: Hepatocellular carcinoma (HCC) ranks as the third most prevalent cancer and is the second leading cause of cancer-related deaths globally. This study sought to evaluate microwave ablation (MWA), radiofrequency ablation (RFA), and percutaneous ethanol injection (PEI)\u2014whether used separately or together (RFA+PEI, MWA+PEI)\u2014for treating single HCC lesions \u22645 cm, focusing on outcomes, survival rates, complications, costs, and recurrence rates. Methods: This retrospective\u2013prospective research study involved 250 patients with solitary HCC lesions measuring \u22645 cm, recruited from the National Liver Institute at Menoufia University. Patients were evenly divided into five groups, each containing (n = 50): RFA, MWA, PEI, combined RFA+PEI, and combined MWA+PEI. Indications and contraindications adhered to the Barcelona Clinic Liver Cancer (BCLC) guidelines. Results: Three patients were administered antiviral therapy 1\u20132 years after ablation. Average intervention costs were 17,340 \u00b1 700, 31,200 \u00b1 900, 1140 \u00b1 300, 17,500 \u00b1 0.0, and 33,800 \u00b1 0.0 EGP for groups 1 through 5, respectively. Short-term advancement rates were 12%, 8%, 18%, 4%, and 2%. After 36 months, all patients survived six months after ablation. Average survival durations were 2.44 \u00b1 1.17, 2.59 \u00b1 1.02, 2.69 \u00b1 0.99, 2.83 \u00b1 1.06,and 2.91 \u00b1 1.04 years, respectively. Complications were mainly minor (pain, nausea, and low-grade fever); one patient experienced an abscess and biloma post-MWA, one experienced minimal pleural effusion, and two combined-therapy cases had abdominal wall hematoma. Conclusions: RFA, MWA, and PEI\u2014whether used individually or together\u2014are successful treatment choices for early-stage HCC. The combination of MWA and PEI demonstrated the most favorable results, minimal recurrence rates, and the longest duration of progression-free survival.<\/jats:p>","DOI":"10.3390\/diagnostics15233027","type":"journal-article","created":{"date-parts":[[2025,11,27]],"date-time":"2025-11-27T16:31:52Z","timestamp":1764261112000},"page":"3027","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["A Comparative Study of Radiofrequency Ablation, Microwave Ablation, and Percutaneous Ethanol Injection in Treatment of Hepatocellular Carcinoma\u2014A Single-Center Experience"],"prefix":"10.3390","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8970-0286","authenticated-orcid":false,"given":"Mohamed","family":"Abdel-Samiee","sequence":"first","affiliation":[{"name":"Department of Hepatology and Gastroenterology, National Liver Institute, Menoufia University, Shebin El-Kom 32511, Egypt"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reham Reda","family":"Elkazaz","sequence":"additional","affiliation":[{"name":"Department of Hepatology and Gastroenterology, National Liver Institute, Menoufia University, Shebin El-Kom 32511, Egypt"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hazem","family":"Omar","sequence":"additional","affiliation":[{"name":"Department of Radiology, National Liver Institute, Menoufia University, Shebin El-Kom 32511, Egypt"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nada Mohsen","family":"Salama","sequence":"additional","affiliation":[{"name":"Radiology Department, National Cancer Institute, Cairo University, Cairo 11796, Egypt"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Asmaa Ibrahim","family":"Gomaa","sequence":"additional","affiliation":[{"name":"Department of Hepatology and Gastroenterology, National Liver Institute, Menoufia University, Shebin El-Kom 32511, Egypt"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohamed Akl","family":"Rady","sequence":"additional","affiliation":[{"name":"Department of Hepatology and Gastroenterology, National Liver Institute, Menoufia University, Shebin El-Kom 32511, Egypt"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Imam","family":"Waked","sequence":"additional","affiliation":[{"name":"Department of Hepatology and Gastroenterology, National Liver Institute, Menoufia University, Shebin El-Kom 32511, Egypt"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2025,11,27]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Brunese, L., Mercaldo, F., Santone, A., and Vanoli, G.P. (2021, January 18\u201322). Thermal Ablation Treatment Detection by means of Machine Learning. Proceedings of the 2021 International Joint Conference on Neural Networks (IJCNN), Shenzhen, China.","DOI":"10.1109\/IJCNN52387.2021.9533696"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/s12072-018-9919-1","article-title":"Goals and targets for personalized therapy for HCC","volume":"13","author":"Couri","year":"2019","journal-title":"Hepatol. Int."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"10174","DOI":"10.3748\/wjg.v20.i29.10174","article-title":"Clinical outcome of small hepatocellular carcinoma after different treatments: A meta-analysis","volume":"20","author":"Dong","year":"2014","journal-title":"World J. Gastroenterol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1016\/j.prp.2018.07.033","article-title":"Small nucleolar RNA host gene 1: A new biomarker and therapeutic target for cancers","volume":"214","author":"Huang","year":"2018","journal-title":"Pathol.-Res. Pract."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"S30","DOI":"10.4103\/ijmr.IJMR_1812_15","article-title":"Comparison of radiofrequency ablation alone & in combination with percutaneous ethanol injection for management of hepatocellular carcinoma","volume":"146","author":"Kalra","year":"2017","journal-title":"Indian J. Med. Res."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.pvr.2018.12.002","article-title":"Burden of Human papillomavirus (HPV)-related disease and potential impact of HPV vaccines in the Republic of Korea","volume":"7","author":"Kim","year":"2019","journal-title":"Papillomavirus Res."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1186\/s12957-017-1196-2","article-title":"Effects of radiofrequency ablation versus other ablating techniques on hepatocellular carcinomas: A systematic review and meta-analysis","volume":"15","author":"Luo","year":"2017","journal-title":"World J. Surg. Oncol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1002\/cncr.29971","article-title":"Population attributable fractions of risk factors for hepatocellular carcinoma in the United States","volume":"122","author":"Altekruse","year":"2016","journal-title":"Cancer"},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Nief, C., Morhard, R., Chelales, E., Adrianzen Alvarez, D., Bourla BS, I., Lam, C.T., Sag, A.A., Crouch, B.T., Mueller, J.L., and Ramanujam, N. (2021). Polymer-assisted intratumoral delivery of ethanol: Preclinical investigation of safety and efficacy in a murine breast cancer model. PLoS ONE, 16.","DOI":"10.1371\/journal.pone.0234535"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1002\/hep.23181","article-title":"Radiofrequency ablation of hepatocellular carcinoma: Long-term results and prognostic factors in 235 Western patients with cirrhosis","volume":"50","author":"Mahamoudi","year":"2009","journal-title":"Hepatology"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s11864-020-0725-3","article-title":"Curative-intent therapies in localized hepatocellular carcinoma","volume":"21","author":"Mahler","year":"2020","journal-title":"Curr. Treat. Options Oncol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"4756147","DOI":"10.1155\/2018\/4756147","article-title":"Percutaneous ablation for hepatocellular carcinoma: Comparison of various ablation techniques and surgery","volume":"2018","author":"Shiina","year":"2018","journal-title":"Can. J. Gastroenterol. Hepatol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"389","DOI":"10.5582\/bst.2017.01202","article-title":"The clinical management of hepatocellular carcinoma worldwide: A concise review and comparison of current guidelines from 2001 to 2017","volume":"11","author":"Song","year":"2017","journal-title":"Biosci. Trends"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1007\/s00261-015-0355-6","article-title":"Ablation therapy of hepatocellular carcinoma: A comparative study between radiofrequency and microwave ablation","volume":"40","author":"Vogl","year":"2015","journal-title":"Abdom. Imaging"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1055\/s-0043-117410","article-title":"Microwave ablation (MWA): Basics, technique and results in primary and metastatic liver neoplasms\u2013review article","volume":"189","author":"Vogl","year":"2017","journal-title":"R\u00f6Fo-Fortschritte Auf Demgebiet Der R\u00f6ntgenstrahlen Und Der Bildgeb."},{"key":"ref_16","first-page":"105","article-title":"Advances in locoregional therapy for hepatocellular carcinoma combined with immunotherapy and targeted therapy","volume":"4","author":"Xue","year":"2021","journal-title":"J. Interv. Med."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.cgh.2021.05.002","article-title":"Incidence of hepatocellular carcinoma in patients with nonalcoholic fatty liver disease: A systematic review, meta-analysis, and meta-regression","volume":"20","author":"Orci","year":"2022","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1056\/NEJMoa2029349","article-title":"Prospective study of outcomes in adults with nonalcoholic fatty liver disease","volume":"385","author":"Sanyal","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"European Association for the Study of the Liver (EASL) (2018). EASL clinical practice guidelines: Management of hepatocellular carcinoma. J. Hepatol., 69, 182\u2013236.","DOI":"10.1016\/j.jhep.2018.03.019"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1002\/hep.32341","article-title":"HCC incidence after hepatitis C cure among patients with advanced fibrosisor cirrhosis: Ameta-analysis","volume":"76","author":"Lockart","year":"2022","journal-title":"Hepatology"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.1002\/hep.31588","article-title":"A model Based on noninvasive markers predicts very low hepatocellular carcinoma risk after viral Response in hepatitis C virus advanced fibrosis","volume":"72","author":"Manzano","year":"2020","journal-title":"Hepatology"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1016\/j.jhep.2021.11.025","article-title":"HCC risk stratification after cure of hepatitis C in patients with compensated advanced chronic liver disease","volume":"76","author":"Semmler","year":"2022","journal-title":"J. Hepatol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.jhep.2019.10.005","article-title":"Non-invasive prediction of liver-related events in patients with HCV-associated compensated advanced chronic liver disease after oral antivirals","volume":"72","author":"Pons","year":"2020","journal-title":"J. Hepatol."},{"key":"ref_24","first-page":"381","article-title":"Radiofrequency ablation with or without ethanol injection for hepatocellular carcinoma: A systematic review and metaanalysis","volume":"107","author":"Zhu","year":"2016","journal-title":"Minerva Med."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"100289","DOI":"10.1016\/j.jhepr.2021.100289","article-title":"Risk of hepatocellular carcinoma after HCV eradication: Determining the role of portal hypertension by measuring spleen stiffness","volume":"3","author":"Dajti","year":"2021","journal-title":"JHEP Rep."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1111\/jvh.13426","article-title":"Variceal recurrence 4 years post endoscopic band ligation in hepatitis C patients who achieved sustained virological response with oral direct-acting antiviral therapy","volume":"28","author":"Ibrahim","year":"2021","journal-title":"J. Viral Hepat."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/j.jhep.2017.12.014","article-title":"Comparison of the accuracy of AASLD and LI-RADS criteria for the non-invasive diagnosis of HCC smaller than 3 cm","volume":"68","author":"Ronot","year":"2018","journal-title":"J. Hepatol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"9997","DOI":"10.1038\/s41598-018-28337-6","article-title":"Metronomic capecitabine vs. best supportive care in Child-Pugh B hepatocellular carcinoma: A proof of concept","volume":"8","author":"Tovoli","year":"2018","journal-title":"Sci. Rep."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"2997","DOI":"10.3748\/wjg.v21.i10.2997","article-title":"Clinical outcome of medium-sized hepatocellular carcinoma treated with microwave ablation","volume":"21","author":"Sun","year":"2015","journal-title":"World J Gastroenterol."},{"key":"ref_30","first-page":"100328","article-title":"Biochemical predictors of response to immune checkpoint inhibitors in unresectable hepatocellular carcinoma","volume":"27","author":"Rizzo","year":"2021","journal-title":"Cancer Treat. Res. Commun."},{"key":"ref_31","first-page":"97","article-title":"Percutaneous ultrasound-guided radiofrequency electrocautery for the treatment of small hepatocellular carcinoma","volume":"8","author":"Rossi","year":"1993","journal-title":"J. IntervRadiol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"100729","DOI":"10.1016\/j.aohep.2022.100729","article-title":"Combination of radiofrequency ablation and percutaneous ethanol injection versus radiofrequency ablation alone for hepatocellular carcinoma: A systematic review and meta-analysis","volume":"27","author":"Lu","year":"2022","journal-title":"Ann. Hepatol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1080\/02656736.2016.1237681","article-title":"Radiofrequency ablation combined with percutaneous ethanol injection for hepatocellular carcinoma: A systematic review and meta-analysis","volume":"33","author":"Li","year":"2017","journal-title":"Int. J. Hyperth."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1002\/hep.29086","article-title":"AASLD guidelines for the treatment of hepatocellular carcinoma","volume":"67","author":"Heimbach","year":"2018","journal-title":"Hepatology"}],"container-title":["Diagnostics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2075-4418\/15\/23\/3027\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,27]],"date-time":"2025-11-27T16:44:21Z","timestamp":1764261861000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2075-4418\/15\/23\/3027"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,27]]},"references-count":34,"journal-issue":{"issue":"23","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["diagnostics15233027"],"URL":"https:\/\/doi.org\/10.3390\/diagnostics15233027","relation":{},"ISSN":["2075-4418"],"issn-type":[{"type":"electronic","value":"2075-4418"}],"subject":[],"published":{"date-parts":[[2025,11,27]]}}}